HTA as Enabler, Not Blocker: Which Redesign Should Come First to Support Procurement Decisions in Smaller European Health Systems?

About this session

Issue Many smaller European countries, especially but not exclusively in Central Europe, have adopted HTA frameworks modelled on the UK cost-effectiveness paradigm, yet they operate in fundamentally different institutional contexts, with resource constraints, limited data availability, greater sensitivity to short-term budget impact than to cost-effectiveness and institutional traditions where negotiation is the primary mechanism to decide about…

Speakers

• 

  Lou Garrison

  The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

  Moderator

• JM

  Jorge Mestre-Ferrandiz

  Profesor Asociado

  Panelist

• 

  Dávid Dankó

  Ideas & Solutions

  Panelist

• 

  Olivier Wong

  MEDI-QUALITE OMEGA

  Panelist